Johnson & Johnson JNJ earnings Q3 2020


Alex Gorsky, Chairman and CEO of Johnson & Johnson, rings the opening bell to celebrate the 75th anniversary of his company’s listing at the New York Stock Exchange, September 17, 2019.

Brendan McDermid | Reuters

Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat Wall Street’s expectations, led by higher sales in its medical-device unit and higher demand for some of its drugs.

J&J reported an adjusted earnings of $2.20 per share, higher than the $1.98 per share projected by analysts surveyed by Refinitiv. The company generated $21.08 billion in revenue, higher than the $20.2 billion expected and up from $20.72 last year.

The company also raised its full-year…

Source cnbc.com

Dropbox latest San Francisco tech company making remote work permanent

Previous article

Treasury yields fall as traders weigh U.S. coronavirus stimulus prospects

Next article

You may also like

Leave a Reply

Notify of

More in Earnings